JP2021519063A5 - - Google Patents
Info
- Publication number
- JP2021519063A5 JP2021519063A5 JP2020551300A JP2020551300A JP2021519063A5 JP 2021519063 A5 JP2021519063 A5 JP 2021519063A5 JP 2020551300 A JP2020551300 A JP 2020551300A JP 2020551300 A JP2020551300 A JP 2020551300A JP 2021519063 A5 JP2021519063 A5 JP 2021519063A5
- Authority
- JP
- Japan
- Prior art keywords
- population
- cells
- proportion
- marker
- expressed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024020808A JP2024073435A (ja) | 2018-03-23 | 2024-02-15 | 異種ターゲティング構築物を発現するリンパ球 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1804701.9 | 2018-03-23 | ||
| GBGB1804701.9A GB201804701D0 (en) | 2018-03-23 | 2018-03-23 | Lymphocytes expressing heterologous targeting constructs |
| PCT/EP2019/057469 WO2019180279A1 (en) | 2018-03-23 | 2019-03-25 | Lymphocytes expressing heterologous targeting constructs |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024020808A Division JP2024073435A (ja) | 2018-03-23 | 2024-02-15 | 異種ターゲティング構築物を発現するリンパ球 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021519063A JP2021519063A (ja) | 2021-08-10 |
| JP2021519063A5 true JP2021519063A5 (cg-RX-API-DMAC7.html) | 2022-03-30 |
Family
ID=62068083
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020551300A Pending JP2021519063A (ja) | 2018-03-23 | 2019-03-25 | 異種ターゲティング構築物を発現するリンパ球 |
| JP2024020808A Pending JP2024073435A (ja) | 2018-03-23 | 2024-02-15 | 異種ターゲティング構築物を発現するリンパ球 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024020808A Pending JP2024073435A (ja) | 2018-03-23 | 2024-02-15 | 異種ターゲティング構築物を発現するリンパ球 |
Country Status (15)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114651003A (zh) | 2019-09-10 | 2022-06-21 | 黑曜石疗法公司 | 用于可调调节的ca2-il15融合蛋白 |
| GB202013962D0 (en) | 2020-09-04 | 2020-10-21 | Gammadelta Therapeutics Ltd | Immunotherapy composition |
| CN115381965B (zh) * | 2022-09-01 | 2023-03-14 | 广东龄值生物科技有限公司 | 一种γδT细胞功能化的磁性微球、制备方法及其用途 |
| WO2026019861A1 (en) * | 2024-07-15 | 2026-01-22 | Adicet Therapeutics, Inc. | METHODS FOR EXPANDING γδ T CELL POPULATIONS |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| GB8928874D0 (en) | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
| DE69233482T2 (de) | 1991-05-17 | 2006-01-12 | Merck & Co., Inc. | Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen |
| EP0590058B1 (en) | 1991-06-14 | 2003-11-26 | Genentech, Inc. | HUMANIZED Heregulin ANTIBODy |
| ES2136092T3 (es) | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
| WO1993011794A1 (en) | 1991-12-13 | 1993-06-24 | Xoma Corporation | Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| GB9203459D0 (en) | 1992-02-19 | 1992-04-08 | Scotgen Ltd | Antibodies with germ-line variable regions |
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| US5786464C1 (en) | 1994-09-19 | 2012-04-24 | Gen Hospital Corp | Overexpression of mammalian and viral proteins |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US6114148C1 (en) | 1996-09-20 | 2012-05-01 | Gen Hospital Corp | High level expression of proteins |
| CN1294148C (zh) | 2001-04-11 | 2007-01-10 | 中国科学院遗传与发育生物学研究所 | 环状单链三特异抗体 |
| CA2531118C (en) | 2003-07-01 | 2013-01-08 | Immunomedics, Inc. | Multivalent carriers of bi-specific antibodies |
| EP1660186B1 (en) | 2003-08-18 | 2013-12-25 | MedImmune, LLC | Humanization of antibodies |
| US20050042664A1 (en) | 2003-08-22 | 2005-02-24 | Medimmune, Inc. | Humanization of antibodies |
| EP1786918A4 (en) | 2004-07-17 | 2009-02-11 | Imclone Systems Inc | NEW BISPECIFIC ANTIBODY TETRAVALENT |
| KR20140053410A (ko) | 2005-08-19 | 2014-05-07 | 아보트 러보러터리즈 | 이원 가변 도메인 면역글로불린 및 이의 용도 |
| US8940707B2 (en) | 2010-10-28 | 2015-01-27 | Viropharma Incorporated | Maribavir isomers, compositions, methods of making and methods of using |
| EP2710123B1 (en) | 2011-05-19 | 2017-07-12 | Instituto de Medicina Molecular | Cell line of lymphocytes comprising gamma-delta t cells, composition and production method thereof |
| GB201506423D0 (en) * | 2015-04-15 | 2015-05-27 | Tc Biopharm Ltd | Gamma delta T cells and uses thereof |
| RU2756247C2 (ru) | 2014-11-17 | 2021-09-28 | Эдисет Био, Инк. | Генетически модифицированные гамма дельта т-клетки |
| GB201507368D0 (en) * | 2015-04-30 | 2015-06-17 | Ucl Business Plc | Cell |
| JP6799895B2 (ja) | 2015-06-09 | 2020-12-16 | リンファクト−リンフォサイト アクティベイション テクノロジーズ エス.エー. | TCRγδ+T細胞の生産方法 |
| CN108473958A (zh) | 2015-10-30 | 2018-08-31 | 癌症研究技术有限公司 | 非造血组织驻留γδT细胞的扩增及这些细胞的用途 |
| JP6976960B2 (ja) * | 2015-11-27 | 2021-12-08 | カーサリクス プロプライエタリー リミテッド | 遺伝子改変された細胞およびその使用 |
| WO2017190100A1 (en) * | 2016-04-28 | 2017-11-02 | The Trustees Of Dartmouth College | Nucleic acid constructs for co-expression of chimeric antigen receptor and transcription factor, cells containing and therapeutic use thereof |
| CN118421557A (zh) | 2016-05-12 | 2024-08-02 | 阿迪塞特治疗公司 | 选择性扩增γδT细胞群的方法及其组合物 |
| EP3487991B1 (en) * | 2016-07-25 | 2022-09-07 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Methods of producing modified natural killer cells and methods of use |
| GB201707048D0 (en) | 2017-05-03 | 2017-06-14 | King S College London | Expansion of gamma delta cells, compositions, and methods of use thereof |
-
2018
- 2018-03-23 GB GBGB1804701.9A patent/GB201804701D0/en not_active Ceased
-
2019
- 2019-03-25 US US17/040,917 patent/US20210015867A1/en active Pending
- 2019-03-25 IL IL277517A patent/IL277517B2/en unknown
- 2019-03-25 KR KR1020207030413A patent/KR20220029292A/ko active Pending
- 2019-03-25 EP EP19713774.8A patent/EP3768696B1/en active Active
- 2019-03-25 MY MYPI2020004925A patent/MY208877A/en unknown
- 2019-03-25 EP EP21194817.9A patent/EP4015525A3/en active Pending
- 2019-03-25 IL IL317829A patent/IL317829A/en unknown
- 2019-03-25 WO PCT/EP2019/057469 patent/WO2019180279A1/en not_active Ceased
- 2019-03-25 AU AU2019239705A patent/AU2019239705B9/en active Active
- 2019-03-25 CA CA3094766A patent/CA3094766A1/en active Pending
- 2019-03-25 MX MX2020009859A patent/MX2020009859A/es unknown
- 2019-03-25 BR BR112020019143-4A patent/BR112020019143A2/pt unknown
- 2019-03-25 EA EA202092261A patent/EA202092261A1/ru unknown
- 2019-03-25 JP JP2020551300A patent/JP2021519063A/ja active Pending
- 2019-03-25 CN CN201980034162.8A patent/CN112513067A/zh active Pending
-
2020
- 2020-09-22 MX MX2025009862A patent/MX2025009862A/es unknown
- 2020-09-22 MX MX2025009861A patent/MX2025009861A/es unknown
- 2020-09-23 PH PH12020551538A patent/PH12020551538A1/en unknown
-
2024
- 2024-02-15 JP JP2024020808A patent/JP2024073435A/ja active Pending
- 2024-12-02 AU AU2024267110A patent/AU2024267110A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Phan et al. | Stock return forecasting: Some new evidence | |
| JP2013516431A5 (cg-RX-API-DMAC7.html) | ||
| JP2015158565A5 (cg-RX-API-DMAC7.html) | ||
| EP4235549A3 (en) | Rapid distributed consensus on blockchain | |
| JP2020507222A5 (cg-RX-API-DMAC7.html) | ||
| JP2023506251A5 (cg-RX-API-DMAC7.html) | ||
| CN110198739A (zh) | 一种pd-l1抗体药物组合物及其用途 | |
| JP2018501356A5 (cg-RX-API-DMAC7.html) | ||
| JP2019212805A5 (cg-RX-API-DMAC7.html) | ||
| JP2015505089A5 (cg-RX-API-DMAC7.html) | ||
| JP2014063186A5 (cg-RX-API-DMAC7.html) | ||
| JP2014525395A5 (cg-RX-API-DMAC7.html) | ||
| MX2016014241A (es) | Composicion de limpieza que contiene una polieteramina. | |
| MX2016000003A (es) | Metodo y aparato para generar, a partir de una representacion de dominio de coeficiente de señales hoa, una representacion de dominio mixto espacial/coeficiente de dichas señales hoa. | |
| Ji et al. | Effective spreading from multiple leaders identified by percolation in the susceptible-infected-recovered (SIR) model | |
| JP2015041624A5 (cg-RX-API-DMAC7.html) | ||
| JP2023532185A5 (cg-RX-API-DMAC7.html) | ||
| JP2012084862A5 (cg-RX-API-DMAC7.html) | ||
| JP2017528470A5 (cg-RX-API-DMAC7.html) | ||
| WO2020086362A3 (en) | Relativistic quantum computer / quantum gravity computer | |
| JP2024507779A5 (cg-RX-API-DMAC7.html) | ||
| EP3999696C0 (en) | GYPSUM INTERLOCKING SURFACE BUILDING PRODUCTS, MANUFACTURING METHODS | |
| WO2015150431A3 (fr) | Plaque de coffrage pour murs ou voûtes | |
| JP2019506134A5 (cg-RX-API-DMAC7.html) | ||
| Hao et al. | The pessimistic diagnosabilities of some general regular graphs |